RNA interference and nanomedicine join forces to fight dangerous fungal infections
Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...
American Council on Science and Health5d
RNAi Technology Shows Promise in Combating Deadly Honeybee Pest
RNAi – functions specifically to silence, or deactivate, genes. Among other applications, it promises to be groundbreaking as ...
Nanowerk4d
Nanomedicine with siRNA shows first effectiveness against the human-pathogenic fungus Aspergillus fumigatus
The study demonstrates that this RNAi approach shuts down vital fungal genes, thereby inhibiting pathogen growth - a ...
Informationsdienst Wissenschaft4d
Major Progress in the Development of New Medications Against Dangerous Fungal Infections
Home > Pressemitteilung: Major Progress in the Development of ...
Le Lézard2d
FDA Approves Qfitliatm (fitusiran), the First siRNA (RNAi Therapeutic) for the Treatment of Hemophilia A or B
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today highlighted the significance of the U.S. Food and Drug Administration's (FDA) approval of Qfitliatm (fitusiran), the sixth ...
Morningstar2d
FDA Approves Qfitlia™ (fitusiran), the First siRNA (RNAi Therapeutic) for the Treatment of Hemophilia A or B
About RNAi Therapeutics RNAi (RNA interference) is a natural cellular ... or so,” and was recognized with the award of the 2006 Nobel Prize for Physiology or Medicine. By harnessing the natural ...
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
pharmaphorum2d
RNAi biotech Atalanta debuts with $110m plus Biogen and Roche CNS tie-ups
Co-founded by Craig Mello, who won the Nobel Prize for Physiology or Medicine in 2006 for his work on RNAi, the company says the technology could be used to treat central nervous system diseases ...